Glucose Biosensor Market By End User (hospitals, Homecare Diagnostics And Other End Users) - Global Industry Analysis And Forecast To 2023
Published On : July 2018 Pages : 180 Category: Medical Devices Report Code : HC071098
Industry Outlook and Trend Analysis
The Glucose Biosensors Market is expected to witness considerable growth during the forecast period. Glucose biosensors are broadly being utilized for estimating centralization of glucose in diabetic patients. Proteins including nucleic acids, catalysts, and others are a portion of the prevalently utilized biosensors to comprehend the glucose levels in a patient. The worldwide glucose biosensors market is encountering a development spurt because of expanding number of diabetic patients over the globe. The World Health Organization (WHO) expresses that around 347 million individuals are determined to have high glucose levels over the globe. In light of this measurement, the association additionally expresses that diabetes is relied upon to be the main source of death by the end of 2030. In addition, expanding commonness of diabetes across the globe is probably going to be the essential development driver for the worldwide glucose biosensors market in the upcoming years.
End User Outlook and Trend Analysis
On the basis of end user, the market is segmented into hospitals, Homecare Diagnostics and other end users. Homecare diagnostics segment is expected to witness highest share in terms of revenue over the forecast period. The homecare diagnostics section includes the utilization of purpose of care gadgets including hand-held glucose meters. These gadgets are convenient, simple to-utilize, practical, and yield speedy outcomes. Moreover, the utilization of these gadgets diminishes frequent visits to the doctor's facilities.
Regional Outlook and Trend Analysis
North America is relied upon to lead the market as far as income and is likewise foreseen to develop quickly amid the conjecture time frame. Developing burden of diabetes is one of the key variables crediting to quickened local market development. Diabetes is relied upon to be one of the main sources of sickness and passing in the U.S. area.
Competitive Insights
The leading players in the market are Roche, Bayer, LifeScan Inc., and Abbott and others. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
The Glucose Biosensor Market is segmented as follows-
By End User:
- Hospitals
- Homecare Diagnostics
- Other End Users
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- South Africa
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2023?
- What will be the industry market growth from 2017 to 2023?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Glucose Biosensor Market, By End User, Estimates and Forecast, 2014-2023($Million)
· Hospitals
· Homecare Diagnostics
· Other End Users
· Glucose Biosensor Market, By Region, Estimates and Forecast, 2014-2023($Million)
o North America
§ North America Glucose Biosensor Market, By Country
o U.S. Glucose Biosensor Market
o Canada Glucose Biosensor Market
o Mexico Glucose Biosensor Market
o Europe
§ Europe Glucose Biosensor Market, By Country
o Germany Glucose Biosensor Market
o UK Glucose Biosensor Market
o France Glucose Biosensor Market
o Russia Glucose Biosensor Market
o Italy Glucose Biosensor Market
o Rest of Europe Glucose Biosensor Market
o Asia-Pacific
§ Asia-Pacific Glucose Biosensor Market, By Country
o China Glucose Biosensor Market
o Japan Glucose Biosensor Market
o South Korea Glucose Biosensor Market
o India Glucose Biosensor Market
o Southeast Asia Glucose Biosensor Market
o Rest of Asia-Pacific Glucose Biosensor Market
o South America
§ South America Glucose Biosensor Market
o Brazil Glucose Biosensor Market
o Argentina Glucose Biosensor Market
o Columbia Glucose Biosensor Market
o South Africa Glucose Biosensor Market
o Rest of South America Glucose Biosensor Market
o Middle East and Africa
§ Middle East and Africa Glucose Biosensor Market
o Saudi Arabia Glucose Biosensor Market
o UAE Glucose Biosensor Market
o Egypt Glucose Biosensor Market
o Nigeria Glucose Biosensor Market
o South Africa Glucose Biosensor Market
o Rest of MEA Glucose Biosensor Market
Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.3.1. Emerging Countries to Offer Lucrative Growth Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market States and Outlook (2017-2023)
4.1.2. Canada Market States and Outlook (2017-2023)
4.1.3. Mexico Market States and Outlook (2017-2023)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market States and Outlook (2017-2023)
4.2.2. France Market States and Outlook (2017-2023)
4.2.3. UK Market States and Outlook (2017-2023)
4.2.4. Russia Market States and Outlook (2017-2023)
4.2.5. Italy Market States and Outlook (2017-2023)
4.2.6. Rest of Europe Market States and Outlook (2017-2023)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market States and Outlook (2017-2023)
4.3.2. Japan Market States and Outlook (2017-2023)
4.3.3. Korea Market States and Outlook (2017-2023)
4.3.4. India Market States and Outlook (2017-2023)
4.3.5. Rest of Asia-Pacific Market States and Outlook (2017-2023)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market States and Outlook (2017-2023)
4.4.2. Argentina Market States and Outlook (2017-2023)
4.4.3. Columbia Market States and Outlook (2017-2023)
4.4.4. Rest of South America Market States and Outlook (2017-2023)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market States and Outlook (2017-2023)
4.5.2. UAE Market States and Outlook (2017-2023)
4.5.3. Egypt Market States and Outlook (2017-2023)
4.5.4. Nigeria Market States and Outlook (2017-2023)
4.5.5. South Africa Market States and Outlook (2017-2023)
4.5.6. Rest of MEA Market States and Outlook (2017-2023)
5. Glucose Biosensor Market, By End User
5.1. Introduction
5.2. Global Glucose Biosensor Sales, Revenue and Market Share by End User (2017-2027)
5.2.1. Global Glucose Biosensor Sales and Sales Share by End User (2017-2027)
5.2.2. Global Glucose Biosensor Revenue and Revenue Share by End User (2017-2027)
5.3. Hospitals
5.3.1. Global Hospitals Sales and Growth Rate (2017-2027)
5.4. Homecare Diagnostics
5.4.1. Global Homecare Diagnostics Sales and Growth Rate (2017-2027)
5.5. Other End Users
5.5.1. Global Other End Users Sales and Growth Rate (2017-2027)
6. Glucose Biosensor Market, By Region
6.1. Introduction
6.2. Global Glucose Biosensor Sales, Revenue and Market Share by Regions
6.2.1. Global Glucose Biosensor Sales by Regions (2017-2027)
6.2.2. Global Glucose Biosensor Revenue by Regions (2017-2027)
6.3. North America Glucose Biosensor by Countries
6.3.1. North America Glucose Biosensor Sales and Growth Rate (2017-2027)
6.3.2. North America Glucose Biosensor Revenue and Growth Rate (2017-2027)
6.3.3. North America Glucose Biosensor Sales by Countries (2017-2027)
6.3.4. North America Glucose Biosensor Revenue (Million USD) by Countries (2017-2027)
6.3.5. U.S.
6.3.5.1. United States Glucose Biosensor Sales and Growth Rate (2017-2027)
6.3.5.2. United States Glucose Biosensor Revenue (Millions USD) and Growth Rate (2017-2027)
6.3.6. Canada
6.3.6.1. Canada Glucose Biosensor Sales and Growth Rate (2017-2027)
6.3.6.2. Canada Glucose Biosensor Sales (Millions USD) and Growth Rate (2017-2027)
6.3.7. Mexico
6.3.7.1. Mexico Glucose Biosensor Sales and Growth Rate (2017-2027)
6.3.7.2. Mexico Glucose Biosensor Revenue (Millions USD) and Growth Rate (2017-2027)
6.4. Europe Glucose Biosensor by Countries
6.4.1. Europe Glucose Biosensor Sales and Growth Rate (2017-2027)
6.4.2. Europe Glucose Biosensor Revenue and Growth Rate (2017-2027)
6.4.3. Europe Glucose Biosensor Sales by Countries (2017-2027)
6.4.4. Europe Glucose Biosensor Revenue (Million USD) by Countries (2017-2027)
6.4.5. Germany
6.4.5.1. Germany Glucose Biosensor Sales and Growth Rate (2017-2027)
6.4.5.2. Germany Glucose Biosensor Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.6. UK
6.4.6.1. UK Glucose Biosensor Sales and Growth Rate (2017-2027)
6.4.6.2. UK Glucose Biosensor Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.7. France
6.4.7.1. France Glucose Biosensor Sales and Growth Rate (2017-2027)
6.4.7.2. France Glucose Biosensor Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.8. Russia
6.4.8.1. Russia Glucose Biosensor Sales and Growth Rate (2017-2027)
6.4.8.2. Russia Glucose Biosensor Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.9. Italy
6.4.9.1. Italy Glucose Biosensor Sales and Growth Rate (2017-2027)
6.4.9.2. Italy Glucose Biosensor Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.10. Rest of Europe
6.4.10.1. Rest of Europe Glucose Biosensor Sales and Growth Rate (2017-2027)
6.4.10.2. Rest of Europe Glucose Biosensor Revenue (Millions USD) and Growth Rate (2017-2027)
6.5. Asia-Pacific
6.5.1. Asia-Pacific Glucose Biosensor Sales and Growth Rate (2017-2027)
6.5.2. Asia-Pacific Glucose Biosensor Revenue and Growth Rate (2017-2027)
6.5.3. Asia-Pacific Glucose Biosensor Sales by Countries (2017-2027)
6.5.4. Asia-Pacific Glucose Biosensor Revenue (Million USD) by Countries (2017-2027)
6.5.5. China
6.5.5.1. China Glucose Biosensor Sales and Growth Rate (2017-2027)
6.5.5.2. China Glucose Biosensor Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.6. Japan
6.5.6.1. Japan Glucose Biosensor Sales and Growth Rate (2017-2027)
6.5.6.2. Japan Glucose Biosensor Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.7. Korea
6.5.7.1. Korea Glucose Biosensor Sales and Growth Rate (2017-2027)
6.5.7.2. Korea Glucose Biosensor Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.8. India
6.5.8.1. India Glucose Biosensor Sales and Growth Rate (2017-2027)
6.5.8.2. India Glucose Biosensor Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.9. Southeast Asia
6.5.9.1. Southeast Asia Glucose Biosensor Sales and Growth Rate (2017-2027)
6.5.9.2. Southeast Asia Glucose Biosensor Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.10. Rest of Asia-Pacific
6.5.10.1. Rest of Asia-Pacific Glucose Biosensor Sales and Growth Rate (2017-2027)
6.5.10.2. Rest of Asia-Pacific Glucose Biosensor Revenue (Millions USD) and Growth Rate (2017-2027)
6.6. South America
6.6.1. South America Glucose Biosensor Sales and Growth Rate (2017-2027)
6.6.2. South America Glucose Biosensor Revenue and Growth Rate (2017-2027)
6.6.3. South America Glucose Biosensor Sales by Countries (2017-2027)
6.6.4. South America Glucose Biosensor Revenue (Million USD) by Countries (2017-2027)
6.6.5. Brazil
6.6.5.1. Brazil Glucose Biosensor Sales and Growth Rate (2017-2027)
6.6.5.2. Brazil Glucose Biosensor Revenue (Millions USD) and Growth Rate (2017-2027)
6.6.6. Argentina
6.6.6.1. Argentina Glucose Biosensor Sales and Growth Rate (2017-2027)
6.6.6.2. Argentina Glucose Biosensor Revenue (Millions USD) and Growth Rate (2017-2027)
6.6.7. Columbia
6.6.7.1. Columbia Glucose Biosensor Sales and Growth Rate (2017-2027)
6.6.7.2. Columbia Glucose Biosensor Revenue (Millions USD) and Growth Rate (2017-2027)
6.6.8. Rest of South America
6.6.8.1. Rest of South America Glucose Biosensor Sales and Growth Rate (2017-2027)
6.6.8.2. Rest of South America Glucose Biosensor Revenue (Millions USD) and Growth Rate (2017-2027)
6.7. Middle East and Africa
6.7.1. Middle East and Africa Glucose Biosensor Sales and Growth Rate (2017-2027)
6.7.2. Middle East and Africa Glucose Biosensor Revenue and Growth Rate (2017-2027)
6.7.3. Middle East and Africa Glucose Biosensor Sales by Countries (2017-2027)
6.7.4. Middle East and Africa Glucose Biosensor Revenue (Million USD) by Countries (2017-2027)
6.7.5. Saudi Arabia
6.7.5.1. Saudi Arabia Glucose Biosensor Sales and Growth Rate (2017-2027)
6.7.5.2. Saudi Arabia Glucose Biosensor Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.6. United Arab Emirates
6.7.6.1. United Arab Emirates Glucose Biosensor Sales and Growth Rate (2017-2027)
6.7.6.2. United Arab Emirates Glucose Biosensor Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.7. Egypt
6.7.7.1. Egypt Glucose Biosensor Sales and Growth Rate (2017-2027)
6.7.7.2. Egypt Glucose Biosensor Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.8. Nigeria
6.7.8.1. Nigeria Glucose Biosensor Sales and Growth Rate (2017-2027)
6.7.8.2. Nigeria Glucose Biosensor Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.9. South Africa
6.7.9.1. South Africa Glucose Biosensor Sales and Growth Rate (2017-2027)
6.7.9.2. South Africa Glucose Biosensor Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.10. Rest of Middle East and Africa
6.7.10.1. Rest of Middle East and Africa Glucose Biosensor Sales and Growth Rate (2017-2027)
6.7.10.2. Rest of Middle East and Africa Glucose Biosensor Revenue (Millions USD) and Growth Rate (2017-2027)
7. Company Profiles
7.1. Roche Diagnostics
7.1.1. Business Overview
7.1.2. Product Portfolio
7.1.3. Strategic Developments
7.1.4. Sales, Revenue and Market Share
7.2. LifeScan Inc.
7.2.1. Business Overview
7.2.2. Product Portfolio
7.2.3. Strategic Developments
7.2.4. Sales, Revenue and Market Share
7.3. Abbott Laboratories
7.3.1. Business Overview
7.3.2. Product Portfolio
7.3.3. Strategic Developments
7.3.4. Sales, Revenue and Market Share
7.4. Bayer
7.4.1. Business Overview
7.4.2. Product Portfolio
7.4.3. Strategic Developments
7.4.4. Sales, Revenue and Market Share
7.5. Medtronic Inc.
7.5.1. Business Overview
7.5.2. Product Portfolio
7.5.3. Strategic Developments
7.5.4. Sales, Revenue and Market Share
7.6. Pinnacle Medical Solutions Inc.
7.6.1. Business Overview
7.6.2. Product Portfolio
7.6.3. Strategic Developments
7.6.4. Sales, Revenue and Market Share
7.7. AgaMatrix Inc.
7.7.1. Business Overview
7.7.2. Product Portfolio
7.7.3. Strategic Developments
7.7.4. Sales, Revenue and Market Share
7.8. Sanofi S.A.
7.8.1. Business Overview
7.8.2. Product Portfolio
7.8.3. Strategic Developments
7.8.4. Sales, Revenue and Market Share
7.9. BioSense Medical Devices, LLC
7.9.1. Business Overview
7.9.2. Product Portfolio
7.9.3. Strategic Developments
7.9.4. Sales, Revenue and Market Share
7.10. Nova Biomedical
7.10.1. Business Overview
7.10.2. Product Portfolio
7.10.3. Strategic Developments
7.10.4. Sales, Revenue and Market Share
8. Global Glucose Biosensor Market Competition, by Manufacturer
8.1. Global Glucose Biosensor Sales and Market Share by Manufacturer (2017-2017)
8.2. Global Glucose Biosensor Revenue and Market Share by Manufacturer (2017-2017)
8.3. Global Glucose Biosensor Price by Manufacturer (2017-2017)
8.4. Top 5 Glucose Biosensor Manufacturer Market Share
8.5. Market Competition Trend
9. Glucose Biosensor Market Forecast (2027-2023)
9.1. Global Glucose Biosensor Sales, Revenue (Millions USD) and Growth Rate (2027-2023)
9.2. Glucose Biosensor Market Forecast by Regions (2027-2023)
9.2.1. North America Glucose Biosensor Market Forecast (2027-2023)
9.2.1.1. United States Glucose Biosensor Market Forecast (2027-2023)
9.2.1.2. Canada Glucose Biosensor Market Forecast (2027-2023)
9.2.1.3. Mexico Glucose Biosensor Market Forecast (2027-2023)
9.2.2. Europe Glucose Biosensor Market Forecast (2027-2023)
9.2.2.1. Germany Glucose Biosensor Market Forecast (2027-2023)
9.2.2.2. United Kingdom Glucose Biosensors Market Forecast (2027-2023)
9.2.2.3. France Glucose Biosensor Market Forecast (2027-2023)
9.2.2.4. Russia Glucose Biosensor Market Forecast (2027-2023)
9.2.2.5. Italy Glucose Biosensor Market Forecast (2027-2023)
9.2.2.6. Rest of the Europe Glucose Biosensor Market Forecast (2027-2023)
9.2.3. Asia-Pacific Glucose Biosensor Market Forecast (2027-2023)
9.2.3.1. China Glucose Biosensor Market Forecast (2027-2023)
9.2.3.2. Japan Glucose Biosensor Market Forecast (2027-2023)
9.2.3.3. Korea Glucose Biosensor Market Forecast (2027-2023)
9.2.3.4. India Glucose Biosensor Market Forecast (2027-2023)
9.2.3.5. Southeast Asia Glucose Biosensor Market Forecast (2027-2023)
9.2.3.6. Rest of Asia-Pacific Glucose Biosensor Market Forecast (2027-2023)
9.2.4. South America Glucose Biosensor Market Forecast (2027-2023)
9.2.4.1. Brazil Glucose Biosensor Market Forecast (2027-2023)
9.2.4.2. Argentina Glucose Biosensor Market Forecast (2027-2023)
9.2.4.3. Columbia Glucose Biosensor Market Forecast (2027-2023)
9.2.4.4. Rest of South America Glucose Biosensor Market Forecast (2027-2023)
9.2.5. Middle East and Africa Glucose Biosensor Market Forecast (2027-2023)
9.2.5.1. Saudi Arabia Glucose Biosensor Market Forecast (2027-2023)
9.2.5.2. UAE Glucose Biosensor Market Forecast (2027-2023)
9.2.5.3. Egypt Glucose Biosensor Market Forecast (2027-2023)
9.2.5.4. Nigeria Glucose Biosensor Market Forecast (2027-2023)
9.2.5.5. South Africa Glucose Biosensor Market Forecast (2027-2023)
9.2.5.6. Rest of MEA Glucose Biosensor Market Forecast (2027-2023)
9.3. Glucose Biosensor Market Forecast by End User (2027-2023)
9.3.1. Global Glucose Biosensor Sales Forecast by End User (2027-2023)
9.3.2. Global Glucose Biosensor Sales Market Share Forecast by End User (2027-2023)
List of Tables
*You can glance through the list of Tables and Figures when you view the sample copy of Glucose Biosensor Market.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|